Am J Perinatol 2016; 33(01): 071-078
DOI: 10.1055/s-0035-1557106
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Neonatal Biomarkers of Inflammation: Correlates of Early Neurodevelopment and Gait in Very-Low-Birth-Weight Preterm Children

Jessica Rose
1   Department of Orthopaedic Surgery, Stanford University School of Medicine, Stanford, California
2   Motion and Gait Analysis Laboratory, Lucile Packard Children's Hospital, Stanford, California
,
Rachel Vassar
1   Department of Orthopaedic Surgery, Stanford University School of Medicine, Stanford, California
,
Katelyn Cahill-Rowley
1   Department of Orthopaedic Surgery, Stanford University School of Medicine, Stanford, California
2   Motion and Gait Analysis Laboratory, Lucile Packard Children's Hospital, Stanford, California
3   Department of Bioengineering, Stanford University, Stanford, California
,
Susan R. Hintz
4   Division of Neonatal and Developmental Medicine, Stanford University School of Medicine, Stanford, California
,
David K. Stevenson
4   Division of Neonatal and Developmental Medicine, Stanford University School of Medicine, Stanford, California
› Author Affiliations
Further Information

Publication History

30 April 2015

01 June 2015

Publication Date:
24 July 2015 (online)

Abstract

Objective Neonatal biomarkers of inflammation were examined in relation to early neurodevelopment and gait in very-low-birth-weight (VLBW) preterm children. We hypothesized that preterm infants exposed to higher levels of neonatal inflammation would demonstrate lower scores on Bayley Scales of Infant Toddler Development, 3rd ed. (BSID-III) and slower gait velocity at 18 to 22 months adjusted age.

Study Design A total of 102 VLBW preterm infants (birthweight [BW] ≤ 1,500 g, gestational age [GA] ≤ 32 weeks) admitted to neonatal intensive care unit [NICU] were recruited. Neonatal risk factors examined were GA at birth, BW, bronchopulmonary dysplasia, necrotizing enterocolitis, retinopathy of prematurity, sepsis, and serum C-reactive protein (CRP), albumin, and total bilirubin over first 2 postnatal weeks. At 18 to 22 months, neurodevelopment was assessed with BSID-III and gait was assessed with an instrumented mat.

Results Children with neonatal CRP ≥ 0.20 mg/dL (n = 52) versus < 0.20 mg/dL (n = 37) had significantly lower BSID-III composite cognitive (92.0 ± 13.1 vs. 100.1 ± 9.6, p = 0.002), language (83.9 ± 16.0 vs. 95.8 ± 14.2, p < 0.001), and motor scores (90.0 ± 13.2 vs. 98.8 ± 10.1, p = 0.002), and slower gait velocity (84.9 ± 19.0 vs. 98.0 ± 22.4 cm/s, p = 0.004). Higher neonatal CRP correlated with lower cognitive (rho =  − 0.327, p = 0.002), language (rho =  − 0.285, p = 0.007), and motor scores (rho =  − 0.257, p = 0.015), and slower gait (rho =  − 0.298, p = 0.008). Multivariate analysis demonstrated neonatal CRP ≥ 0.20 mg/dL significantly predicted BSID-III cognitive (adjusted R2 = 0.104, p = 0.008), language (adjusted R2 = 0.124, p = 0.001), and motor scores (adjusted R2 = 0.122, p = 0.004).

Conclusions Associations between low-level neonatal inflammation and neurodevelopment suggest early biomarkers that may inform neuroprotective treatment for preterm children.

Funding

This research was supported by the National Institute of Health Clinical and Translational Science Award UL1 RR025744 for the Stanford Center for Clinical and Translational Education and Research (Spectrum) and for the Stanford Center for Clinical Informatics and Stanford Translational Research Integrated Database Environment (STRIDE), and by the Lucile Packard Foundation for Children's Health. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under grant no. DGE-1147470 and was supported by the Chiesi Foundation, Parma, Italy and by the Mary Baracchi Research Fund, Lucile Packard Children's Hospital, Stanford. The authors have stated that they had no interests that might be perceived as posing a conflict or bias and there was no involvement of funders in study design, data collections, data analysis, article preparation, and/or publication decisions.


 
  • References

  • 1 Moore T, Hennessy EM, Myles J , et al. Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studies. BMJ 2012; 345: e7961
  • 2 Williams J, Lee KJ, Anderson PJ. Prevalence of motor-skill impairment in preterm children who do not develop cerebral palsy: a systematic review. Dev Med Child Neurol 2010; 52 (3) 232-237
  • 3 Spittle AJ, Cheong J, Doyle LW , et al. Neonatal white matter abnormality predicts childhood motor impairment in very preterm children. Dev Med Child Neurol 2011; 53 (11) 1000-1006
  • 4 Rose J, Mirmiran M, Butler EE , et al. Neonatal microstructural development of the internal capsule on diffusion tensor imaging correlates with severity of gait and motor deficits. Dev Med Child Neurol 2007; 49 (10) 745-750
  • 5 Rose J, Butler EE, Lamont LE, Barnes PD, Atlas SW, Stevenson DK. Neonatal brain structure on MRI and diffusion tensor imaging, sex, and neurodevelopment in very-low-birthweight preterm children. Dev Med Child Neurol 2009; 51 (7) 526-535
  • 6 Woodward LJ, Clark CAC, Bora S, Inder TE. Neonatal white matter abnormalities an important predictor of neurocognitive outcome for very preterm children. PLoS ONE 2012; 7 (12) e51879
  • 7 Woodward LJ, Moor S, Hood KM , et al. Very preterm children show impairments across multiple neurodevelopmental domains by age 4 years. Arch Dis Child Fetal Neonatal Ed 2009; 94 (5) F339-F344
  • 8 Johnson S, Hennessy E, Smith R, Trikic R, Wolke D, Marlow N. Academic attainment and special educational needs in extremely preterm children at 11 years of age: the EPICure study. Arch Dis Child Fetal Neonatal Ed 2009; 94 (4) F283-F289
  • 9 Maulik PK, Darmstadt GL. Community-based interventions to optimize early childhood development in low resource settings. J Perinatol 2009; 29 (8) 531-542
  • 10 Hagberg H, Mallard C, Ferriero DM , et al. The role of inflammation in perinatal brain injury. Nat Rev Neurol 2015; 11 (4) 192-208
  • 11 Bersani I, Auriti C, Ronchetti MP, Prencipe G, Gazzolo D, Dotta A. Use of early biomarkers in neonatal brain damage and sepsis: state of the art and future perspectives. Biomed Res Int 2015; 2015: 253520
  • 12 Hentges CR, Silveira RC, Procianoy RS , et al. Association of late-onset neonatal sepsis with late neurodevelopment in the first two years of life of preterm infants with very low birth weight. J Pediatr (Rio J) 2014; 90 (1) 50-57
  • 13 Schlapbach LJ, Adams M, Proietti E , et al; Swiss Neonatal Network & Follow-up Group. Outcome at two years of age in a Swiss national cohort of extremely preterm infants born between 2000 and 2008. BMC Pediatr 2012; 12: 198
  • 14 Hintz SR, Kendrick DE, Stoll BJ , et al; NICHD Neonatal Research Network. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics 2005; 115 (3) 696-703
  • 15 Aarnoudse-Moens CSH, Weisglas-Kuperus N, van Goudoever JB, Oosterlaan J. Meta-analysis of neurobehavioral outcomes in very preterm and/or very low birth weight children. Pediatrics 2009; 124 (2) 717-728
  • 16 Beaino G, Khoshnood B, Kaminski M , et al; EPIPAGE Study Group. Predictors of cerebral palsy in very preterm infants: the EPIPAGE prospective population-based cohort study. Dev Med Child Neurol 2010; 52 (6) e119-e125
  • 17 Black S, Kushner I, Samols D. C-reactive Protein. J Biol Chem 2004; 279 (47) 48487-48490
  • 18 Meem M, Modak JK, Mortuza R, Morshed M, Islam MS, Saha SK. Biomarkers for diagnosis of neonatal infections: A systematic analysis of their potential as a point-of-care diagnostics. J Glob Health 2011; 1 (2) 201-209
  • 19 Harteman JC, Nikkels PGJ, Benders MJNL, Kwee A, Groenendaal F, de Vries LS. Placental pathology in full-term infants with hypoxic-ischemic neonatal encephalopathy and association with magnetic resonance imaging pattern of brain injury. J Pediatr 2013; 163 (4) 968-95.e2
  • 20 Rose J, Vassar R, Cahill-Rowley K , et al. Neonatal physiological correlates of near-term brain development on MRI and DTI in very-low-birth-weight preterm infants. Neuroimage Clin 2014; 5: 169-177
  • 21 Silveira RC, Procianoy RS. High plasma cytokine levels, white matter injury and neurodevelopment of high risk preterm infants: assessment at two years. Early Hum Dev 2011; 87 (6) 433-437
  • 22 Carlo WA, McDonald SA, Tyson JE , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Cytokines and neurodevelopmental outcomes in extremely low birth weight infants. J Pediatr 2011; 159 (6) 919-25.e3
  • 23 Badaly D, Adolph KE. Beyond the average: walking infants take steps longer than their leg length. Infant Behav Dev 2008; 31 (3) 554-558
  • 24 Yakut I, Tayman C, Oztekin O, Namuslu M, Karaca F, Kosus A. Ischemia-modified albumin may be a novel marker for the diagnosis and follow-up of necrotizing enterocolitis. J Clin Lab Anal 2014; 28 (3) 170-177
  • 25 Oh W, Stevenson DK, Tyson JE , et al; NICHD Neonatal Research Network Bethesda MD. Influence of clinical status on the association between plasma total and unbound bilirubin and death or adverse neurodevelopmental outcomes in extremely low birth weight infants. Acta Paediatr 2010; 99 (5) 673-678
  • 26 Calligaris SD, Bellarosa C, Giraudi P, Wennberg RP, Ostrow JD, Tiribelli C. Cytotoxicity is predicted by unbound and not total bilirubin concentration. Pediatr Res 2007; 62 (5) 576-580
  • 27 Morris BH, Oh W, Tyson JE , et al; NICHD Neonatal Research Network. Aggressive vs. conservative phototherapy for infants with extremely low birth weight. N Engl J Med 2008; 359 (18) 1885-1896